Avanos Medical Files 8-K: Regulation FD & Exhibits
Ticker: AVNS · Form: 8-K · Filed: May 13, 2024 · CIK: 1606498
| Field | Detail |
|---|---|
| Company | Avanos Medical, INC. (AVNS) |
| Form Type | 8-K |
| Filed Date | May 13, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, financial-disclosure
Related Tickers: AVNS
TL;DR
AVNS filed an 8-K for Reg FD and exhibits. Standard filing, no major news in excerpt.
AI Summary
On May 13, 2024, Avanos Medical, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but it indicates a standard regulatory filing.
Why It Matters
This filing serves as a public record of Avanos Medical's regulatory compliance and disclosure of financial information, which is crucial for investors to stay informed.
Risk Assessment
Risk Level: low — The filing is a routine regulatory disclosure and does not appear to contain any new material adverse information.
Key Players & Entities
- AVANOS MEDICAL, INC. (company) — Registrant
- May 13, 2024 (date) — Date of Report
- Delaware (jurisdiction) — State of incorporation
- 001-36440 (identifier) — SEC File Number
- 46-4987888 (identifier) — I.R.S. Employer Identification No.
- 5405 Windward Parkway Suite 100 South Alpharetta, Georgia 30004 (address) — Principal executive offices
- Halyard Health, Inc. (company) — Former company name
FAQ
What is the primary purpose of this 8-K filing by Avanos Medical, Inc.?
The filing is primarily for Regulation FD Disclosure and to report Financial Statements and Exhibits.
On what date was this 8-K report filed?
The report was filed on May 13, 2024.
In which state is Avanos Medical, Inc. incorporated?
Avanos Medical, Inc. is incorporated in Delaware.
What is the principal executive office address for Avanos Medical, Inc.?
The principal executive office is located at 5405 Windward Parkway Suite 100 South, Alpharetta, Georgia 30004.
Has Avanos Medical, Inc. previously operated under a different name?
Yes, the company was formerly known as Halyard Health, Inc.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2024-05-13 07:21:15
Key Financial Figures
- $0.01 — nge on which registered Common Stock - $0.01 Par Value AVNS New York Stock Exchange
Filing Documents
- avns-20240513.htm (8-K) — 27KB
- avns05132024form8k_ex991.htm (EX-99.1) — 8KB
- avanoslogo.jpg (GRAPHIC) — 15KB
- avns-20240513_g1.jpg (GRAPHIC) — 15KB
- 0001606498-24-000060.txt ( ) — 222KB
- avns-20240513.xsd (EX-101.SCH) — 2KB
- avns-20240513_lab.xml (EX-101.LAB) — 22KB
- avns-20240513_pre.xml (EX-101.PRE) — 13KB
- avns-20240513_htm.xml (XML) — 3KB
01 Regulation FD Disclosure
Item 7.01 Regulation FD Disclosure On May 13, 2024, Avanos Medical, Inc. (the "Company") issued a press release announcing that Sigfrido (Sig) Delgado has been appointed as the Company's Senior Vice President, Integrated Supply Chain. A copy of such press release is furnished as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference. The information presented in Item 7.01 of this Current Report on Form 8-K and Exhibit 99.1 shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, unless the Company specifically states that the information is to be considered "filed" under the Exchange Act or specifically incorporates it by reference into a filing under the Securities Act of 1933, as amended, or the Exchange Act.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits (d) Exhibits. The following exhibits are filed with this Current Report on Form 8-K: Exhibit No. Description 99.1 Press Release issued by Avanos Medical, Inc. on May 13, 2024 104 Cover Page Interactive Data File (embedded within the inline XBRL document) SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. AVANOS MEDICAL, INC. Date: May 13, 2024 By: /s/ Mojirade James Mojirade James Senior Vice President and General Counsel